Efficacy and safety of nab-paclitaxel and gemcitabine combined with gabapentin or pregabalin for neoadjuvant therapy of resectable/borderline resectable pancreatic cancer: a prospective, multicenter, open-label, single-arm clinical study.
Active, not recruitingChiCTR2600123968
Lanzhou University Second HospitalPancreatic cancer
Start: 2026-05-07Updated: 2026-05-11